Literature DB >> 16813729

Pulmonary neuroendocrine tumors: What (little) do we know?

Lin-Chi Chen1, William D Travis, Lee M Krug.   

Abstract

Pulmonary neuroendocrine tumors are a distinct subset of tumors composing approximately 20% of all lung cancers. The major categories of pulmonary neuroendocrine tumors include typical and atypical carcinoids, large cell neuroendocrine carcinoma, and the more common small cell lung cancer. They are classified into different categories in the 2004 World Health Organization system, but share structural and morphologic features. Despite these shared features, their clinical characteristics range from indolent to aggressive, and therefore the approach to treatment depends on the histologic subtype. This article discusses the current understanding of the epidemiology, pathologic characteristics, treatment, and prognosis of this spectrum of diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16813729     DOI: 10.6004/jnccn.2006.0051

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  15 in total

1.  Ki-67 expression in pulmonary tumors.

Authors:  Lucian R Chirieac
Journal:  Transl Lung Cancer Res       Date:  2016-10

2.  Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.

Authors:  V Clay; G Papaxoinis; B Sanderson; J W Valle; M Howell; A Lamarca; P Krysiak; P Bishop; D Nonaka; W Mansoor
Journal:  Clin Transl Oncol       Date:  2016-11-15       Impact factor: 3.405

3.  Two cases of the bronchial carcinoid tumors successfully treated with the parenchymal-sparing bronchoplastic resections.

Authors:  Katarzyna Drożdż; Mariusz Chabowski; Angelika Chachaj; Paweł Gać; Małgorzata Szołkowska; Dariusz Janczak; Andrzej Szuba
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

4.  The Post-Surgical Long-Term Behaviour of Lung Carcinoid Tumours.

Authors:  Antonio Tancredi; Lucia Anna Muscarella; Annamaria la Torre; Roberto Scaramuzzi; Vanna Maria Valori; Vito Michele Fazio; Gerardo Scaramuzzi
Journal:  Indian J Surg       Date:  2015-05-31       Impact factor: 0.656

5.  Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy.

Authors:  Morena Fasano; Carminia Maria Della Corte; Federica Papaccio; Fortunato Ciardiello; Floriana Morgillo
Journal:  J Thorac Oncol       Date:  2015-08       Impact factor: 15.609

Review 6.  Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases.

Authors:  Tahani Atieh; Chao H Huang
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

7.  Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.

Authors:  Jung-Mo Ahn; Hye-Jin Sung; Yeon-Hee Yoon; Byung-Gyu Kim; Won Suk Yang; Cheolju Lee; Hae-Min Park; Bum-Jin Kim; Byung-Gee Kim; Soo-Youn Lee; Hyun-Joo An; Je-Yoel Cho
Journal:  Mol Cell Proteomics       Date:  2013-10-01       Impact factor: 5.911

8.  Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung.

Authors:  Melanie Demes; Christoph Aszyk; Holger Bartsch; Joachim Schirren; Annette Fisseler-Eckhoff
Journal:  Cancers (Basel)       Date:  2016-03-25       Impact factor: 6.639

Review 9.  Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature.

Authors:  Sebastian Krug; Michael Boch; Peter Rexin; Andreas Pfestroff; Thomas Gress; Patrick Michl; Anja Rinke
Journal:  BMC Res Notes       Date:  2016-06-27

10.  [Pathological characteristic and clinical management of pulmonary carcinoid].

Authors:  Lei Zhu; Yang Shen-Tu; Jie Zhang; Xiaohong Fan
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.